Clinical Trials Browser

Phase 2 × Colonic Neoplasms × atezolizumab × Clear all

NCT05870800 2025-05-25

NICER

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

NCT05456165 2024-12-31

Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon Cancer

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT03698461 2024-01-31

CLIMB

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms